Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Johnson & Johnson (NYSE:JNJ) and maintained a price target of $215. This reaffirmation of the company's stock rating and price target suggests continued confidence in Johnson & Johnson's performance and potential for growth.
January 09, 2024 | 1:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reaffirms an Overweight rating on Johnson & Johnson with a $215 price target, indicating a positive outlook on the stock's future performance.
The reiteration of an Overweight rating and maintenance of a $215 price target by a reputable analyst could lead to increased investor confidence in Johnson & Johnson. This positive outlook is likely to have a favorable impact on the stock price in the short term as it suggests the company's fundamentals and growth prospects are strong.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100